Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.

Simmons, Archana R; Fourkala, Evangelia Ourania; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sutton, Margie N; Baggerly, Keith; Zheng, Hui; Lu, Karen H; Jacobs, Ian; Skates, Steven; Menon, Usha; Bast, Robert C

Simmons, Archana R; Fourkala, Evangelia Ourania; Gentry-Maharaj, Aleksandra; Ryan, Andy; Sutton, Margie N; Baggerly, Keith; Zheng, Hui; Lu, Karen H; Jacobs, Ian; Skates, Steven; Menon, Usha; Bast, Robert C.

Affiliation

Simmons AR; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Fourkala EO; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Gentry-Maharaj A; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Ryan A; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Sutton MN; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Baggerly K; Department of Bioinformatics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Zheng H; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.
Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Jacobs I; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Skates S; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.
Menon U; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Bast RC; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas. rbast@mdanderson.org.

Cancer Prev Res (Phila) ; 12(6): 391-400, 2019 06.

Article de En | MEDLINE | ID: mdl-30967390

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Marqueurs biologiques tumoraux / Tumeurs de l'endomètre / Cystadénocarcinome séreux / Adénocarcinome à cellules claires / Adénocarcinome mucineux / Antigènes CA-125 Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limites: Aged / Female / Humans / Middle aged Langue: En Journal: Cancer Prev Res (Phila) Sujet du journal: NEOPLASIAS Année: 2019 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google